SCHEDULE 13D/A: Coliseum Capital Increases Stake in Purple Innovation, Provides Additional $19 Million Loan

Coliseum Capital Management and its affiliates have increased their beneficial ownership in Purple Innovation, Inc. to 49.9% and provided an additional $19 million in senior secured term loan financing, alongside new warrants.

Summary

• Coliseum Capital Management, LLC and its affiliates, including Adam Gray and Christopher Shackelton, collectively report a beneficial ownership of 60,455,908 shares of Purple Innovation, Inc.'s Class A Common Stock, representing 49.9% of the outstanding shares as of March 7, 2025.
• This ownership includes 46,855,291 shares of Class A Stock and 13,600,617 shares currently acquirable upon exercise of Warrants, subject to a 49.9% Beneficial Ownership Cap.
• Purple Innovation, Inc. entered into an amendment to its Amended and Restated Credit Agreement on March 12, 2025, increasing the senior secured term loan facility by $19.0 million, bringing the total facility to $80.0 million.
• The Incremental Loan bears the same interest rate as the Initial Loan, payable in cash or in kind at the Company's option.
• In connection with the loan amendment, the Company issued Incremental Warrants to the 2025 Term Loan Lenders (including Coliseum Capital Partners, L.P. and a Separate Account) to purchase 6,229,508 shares of Class A Stock at an exercise price of $1.50 per share.
• Coliseum Capital Partners, L.P. received warrants for 5,106,154 shares, and a Separate Account received warrants for 1,123,354 shares.
• The Incremental Warrants are exercisable for cash or on a cashless basis and expire on the ten-year anniversary of issuance.
• A Second Amended and Restated Registration Rights Agreement was also executed on March 12, 2025, providing for the registration of the Warrants, shares issuable upon exercise, and existing Class A Stock held by the Holders (Coliseum Capital Partners, L.P., Separate Account, and Coliseum Capital Co-Invest III, L.P.).
• The Issuer is responsible for the Holders' expenses related to the registration and sale of these securities, excluding underwriting discounts or selling commissions.

Sentiment

Score: 5

Explanation: The sentiment is neutral. While securing additional financing is positive for liquidity, it comes with increased debt and potential shareholder dilution from warrants. The transaction reflects ongoing capital needs and continued support from a major investor, without indicating significant operational improvements or setbacks.

Positives

• Purple Innovation secured an additional $19.0 million in financing, increasing its total senior secured term loan facility to $80.0 million, which provides additional liquidity.
• The continued investment and support from Coliseum Capital, a significant shareholder, indicates confidence in the company's future.
• The ability to request an additional $20.0 million in term loans provides further financial flexibility for the company.

Negatives

• The increase in the term loan facility adds to the company's debt burden.
• The issuance of 6,229,508 new warrants at $1.50 per share introduces potential dilution for existing shareholders upon exercise.
• The company incurred fees of 2% of the outstanding principal of the Initial Loan (paid in kind) and 2% of the Incremental Loan principal (paid in cash) in connection with the amendment.

Risks

• Potential dilution of existing shareholders' equity due to the exercise of the newly issued Incremental Warrants.
• Increased financial leverage and debt servicing obligations due to the expanded senior secured term loan facility.
• Reliance on a single group of lenders (Coliseum Capital and affiliates) for a significant portion of the company's financing.

Future Outlook

The company has the option to request one or more additional term loans up to an aggregate principal amount of $20.0 million, subject to lender approval. The Issuer is also required to file a registration statement by April 11, 2025 (or May 26, 2025, if Form S-3 is unavailable) to register the resale of the Warrants, shares issuable upon their exercise, and existing Class A Stock held by the Holders.

Industry Context

This filing primarily details a significant financing event and ownership update for Purple Innovation, Inc. It reflects the company's ongoing need for capital, which is being met by its largest institutional investor group. While not directly indicative of broader industry trends, it highlights the importance of strong investor relationships for capital-intensive businesses.

Corporate Governance

Related Party Transactions

• Coliseum Capital Partners, L.P. and a Separate Account (an investment advisory client of Coliseum Capital Management, LLC) provided the Incremental Loan and received Incremental Warrants. These entities are part of the Reporting Persons group, which collectively holds a significant beneficial ownership stake in Purple Innovation, Inc., making these related party transactions.

Stakeholder Impact

• Shareholders: Face potential dilution from the exercise of new warrants and increased financial risk due to higher debt levels. However, the financing provides necessary capital for the company's operations.
• Creditors (Coliseum Capital entities): Increased exposure to Purple Innovation through a larger loan facility and warrants, potentially strengthening their influence over the company's strategic direction.
• Company Management: Gains additional capital to support operations and strategic initiatives, but also takes on increased debt obligations and the responsibility to manage the associated risks.

Next Steps

• The Issuer is required to prepare and file a registration statement with the SEC by April 11, 2025 (or May 26, 2025, if Form S-3 is not available) to register the resale of the Warrants and associated Class A Stock.

Key Dates

Recommendation

Keywords

Purple Innovation, Coliseum Capital, SEC filing, Schedule 13D, Class A Common Stock, Warrants, Credit Agreement, Term Loan, Beneficial Ownership, Registration Rights, Debt Financing, Equity Dilution